Royce & Associates LP Sells 192,783 Shares of Alkami Technology, Inc. $ALKT

Key Points

• Royce & Associates cut its Alkami stake by 65.8%, selling 192,783 shares in Q3 and ending the period with 100,156 shares worth about $2.49 million.
• Other institutions ramped up positions—most notably Westfield Capital (+1.9M shares to 3,095,058) and AllianceBernstein (+383,691 to 3,249,114)—bringing institutional ownership to roughly 54.97%.
• Insiders have been selling recently (13,739 shares over 90 days, including the CFO on March 2), while several analysts trimmed price targets and the consensus rating sits at "Hold" with a $28.57 average target as ALKT trades near $16.50.

Royce & Associates LP reduced its holdings in Alkami Technology, Inc. (NASDAQ:ALKT - Free Report) by 65.8% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 100,156 shares of the company's stock after selling 192,783 shares during the quarter. Royce & Associates LP owned 0.10% of Alkami Technology worth $2,488,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of ALKT. Alliancebernstein L.P. grew its holdings in shares of Alkami Technology by 13.4% during the second quarter. Alliancebernstein L.P. now owns 3,249,114 shares of the company's stock worth $97,928,000 after purchasing an additional 383,691 shares in the last quarter. Westfield Capital Management Co. LP lifted its position in Alkami Technology by 160.0% during the third quarter. Westfield Capital Management Co. LP now owns 3,095,058 shares of the company's stock valued at $76,881,000 after purchasing an additional 1,904,474 shares during the last quarter. Champlain Investment Partners LLC grew its stake in Alkami Technology by 18.6% in the 2nd quarter. Champlain Investment Partners LLC now owns 3,064,695 shares of the company's stock worth $92,370,000 after buying an additional 481,642 shares in the last quarter. Riverbridge Partners LLC increased its holdings in shares of Alkami Technology by 7.2% in the 3rd quarter. Riverbridge Partners LLC now owns 2,250,685 shares of the company's stock worth $55,907,000 after buying an additional 151,895 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its position in shares of Alkami Technology by 3.1% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,012,157 shares of the company's stock valued at $60,646,000 after buying an additional 60,094 shares in the last quarter. Institutional investors own 54.97% of the company's stock.

Trending Headlines about Alkami Technology

Here are the key news stories impacting Alkami Technology this week:

• Positive Sentiment: Alkami launched "Automated Stage Match" in its SDK Wizard to speed development and testing for financial-institution partners — a product improvement that can reduce implementation friction and help win or expand client deployments. PR Newswire
• Neutral Sentiment: Reports show an odd/empty short-interest update (short interest reported as 0 shares with a days-to-cover of 0.0), which appears to be a data anomaly and provides no clear directional signal for the stock today.
• Negative Sentiment: Multiple insiders sold shares on March 2: CFO Cassandra Hudson sold 6,869 shares (~$116k at ~$16.90) and CAO Prerna Sachdeva sold 1,352 shares (~$22.8k). Another insider, Douglas Linebarger, also sold 5,518 shares. Insider selling at this scale can be seen as a negative catalyst or a signal of reduced insider conviction. CFO filing: SEC Form 4 (Hudson) · CAO sale: SEC Form 4 (Sachdeva)
• Negative Sentiment: Several research firms recently trimmed price targets (Needham, Citizens JMP, Barclays, JPMorgan), lowering upside expectations and contributing to a consensus "Hold" rating — a headwind for shares until guidance or results improve. Source: MarketBeat summary. MarketBeat analyst notes

Insider Activity at Alkami Technology

In other news, CFO Cassandra Hudson sold 6,869 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $16.90, for a total transaction of $116,086.10. Following the completion of the sale, the chief financial officer owned 286,757 shares of the company's stock, valued at approximately $4,846,193.30. This represents a 2.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Douglas A. Linebarger sold 5,518 shares of Alkami Technology stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $16.90, for a total transaction of $93,254.20. Following the completion of the transaction, the insider directly owned 216,233 shares in the company, valued at approximately $3,654,337.70. The trade was a 2.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 13,739 shares of company stock worth $232,189. 18.10% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Barclays dropped their price objective on shares of Alkami Technology from $25.00 to $21.00 and set an "equal weight" rating for the company in a report on Thursday, February 26th. JPMorgan Chase & Co. dropped their price target on Alkami Technology from $38.00 to $22.00 and set an "overweight" rating for the company in a research note on Wednesday, February 18th. Needham & Company LLC reduced their price objective on Alkami Technology from $32.00 to $22.00 and set a "buy" rating on the stock in a research report on Thursday, February 26th. Weiss Ratings restated a "sell (d-)" rating on shares of Alkami Technology in a research report on Wednesday, January 21st. Finally, Citizens Jmp reduced their price target on shares of Alkami Technology from $40.00 to $28.00 and set a "market outperform" rating on the stock in a research report on Thursday, February 26th. Five investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $28.57.

Alkami Technology Stock Up 0.1%

ALKT opened at $16.50 on Friday. Alkami Technology, Inc. has a 12 month low of $14.11 and a 12 month high of $31.66. The company has a current ratio of 2.09, a quick ratio of 2.09 and a debt-to-equity ratio of 1.01. The business's 50-day moving average price is $19.41 and its 200-day moving average price is $21.77. The company has a market cap of $1.75 billion, a P/E ratio of -35.87 and a beta of 0.57.

Alkami Technology Profile

Alkami Technology, Inc is a provider of cloud-based digital banking and engagement solutions tailored for banks and credit unions. The company's platform offers a comprehensive suite of online and mobile banking features, including bill payment, peer-to-peer transfers, card management, streamlined account opening and real-time alerts, all designed to enhance the end-user experience and drive customer loyalty.

Built on a multi-tenant, software-as-a-service (SaaS) architecture hosted in the cloud, Alkami's platform leverages modern APIs and a partner ecosystem to integrate third-party fintech applications and services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.